• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硕大利什曼原虫LACK抗原是高效寄生于脊椎动物所必需的。

Leishmania major LACK antigen is required for efficient vertebrate parasitization.

作者信息

Kelly Ben L, Stetson Daniel B, Locksley Richard M

机构信息

Howard Hughes Medical Institute, Department of Medicine, University of California San Francisco, San Francisco, CA 94143, USA.

出版信息

J Exp Med. 2003 Dec 1;198(11):1689-98. doi: 10.1084/jem.20031162.

DOI:10.1084/jem.20031162
PMID:14657221
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2194132/
Abstract

The Leishmania major LACK antigen is a key target of the immune response in susceptible BALB/c mice and remains a viable vaccine candidate for human leishmaniasis. We describe the genomic organization of the four lack genes in the L. major diploid genome together with results of selected lack gene targeting. Parasites containing a single lack gene in either the upstream or downstream locus grew comparably to wild-type promastigotes in vitro, but failed to parasitize BALB/c mice efficiently, even in a T cell-deficient environment. The replication of single copy lack mutants as amastigotes was attenuated in macrophages in vitro, and parasites failed to increase in numbers in immunodeficient mice, despite their persistence over months. Complementation with an additional lack copy was sufficient to induce robust lesion development, which also occurred using parasites with two lack genes. Conversely, attempts to generate lack-null parasites failed, suggesting that LACK is required for parasite viability. These data suggest that LACK is critical for effective mammalian parasitization and thus represents a potential drug target for leishmaniasis.

摘要

硕大利什曼原虫的LACK抗原是易感BALB/c小鼠免疫反应的关键靶点,仍然是人类利什曼病可行的疫苗候选物。我们描述了硕大利什曼原虫二倍体基因组中四个lack基因的基因组结构以及选定的lack基因靶向结果。在上游或下游位点含有单个lack基因的寄生虫在体外与野生型前鞭毛体生长相当,但即使在T细胞缺陷环境中也无法有效地寄生BALB/c小鼠。单拷贝lack突变体作为无鞭毛体在体外巨噬细胞中的复制减弱,并且寄生虫在免疫缺陷小鼠中的数量未能增加,尽管它们持续存在数月。用额外的lack拷贝进行互补足以诱导强烈的病变发展,使用具有两个lack基因的寄生虫也会出现这种情况。相反,产生lack缺失寄生虫的尝试失败了,这表明LACK是寄生虫生存所必需的。这些数据表明,LACK对于有效的哺乳动物寄生至关重要,因此是利什曼病的潜在药物靶点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134e/2194132/14e82221b9eb/20031162f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134e/2194132/5c83bd5ab02d/20031162f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134e/2194132/6715d50047d6/20031162f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134e/2194132/e7cf36abcc0e/20031162f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134e/2194132/d4ecffdcb0c3/20031162f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134e/2194132/0475c6df24f4/20031162f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134e/2194132/1d318b449d60/20031162f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134e/2194132/14e82221b9eb/20031162f7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134e/2194132/5c83bd5ab02d/20031162f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134e/2194132/6715d50047d6/20031162f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134e/2194132/e7cf36abcc0e/20031162f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134e/2194132/d4ecffdcb0c3/20031162f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134e/2194132/0475c6df24f4/20031162f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134e/2194132/1d318b449d60/20031162f6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/134e/2194132/14e82221b9eb/20031162f7.jpg

相似文献

1
Leishmania major LACK antigen is required for efficient vertebrate parasitization.硕大利什曼原虫LACK抗原是高效寄生于脊椎动物所必需的。
J Exp Med. 2003 Dec 1;198(11):1689-98. doi: 10.1084/jem.20031162.
2
The Leishmania major LACK antigen with an immunodominant epitope at amino acids 156 to 173 is not required for early Th2 development in BALB/c mice.利什曼原虫主要种的LACK抗原在氨基酸156至173处有一个免疫显性表位,对于BALB/c小鼠早期Th2细胞的发育并非必需。
Infect Immun. 2004 Dec;72(12):6924-31. doi: 10.1128/IAI.72.12.6924-6931.2004.
3
Control of Leishmania major by a monoclonal alpha beta T cell repertoire.通过单克隆αβT细胞库控制硕大利什曼原虫。
J Immunol. 1998 Jan 15;160(2):884-9.
4
Targeted gene deletion of Leishmania major genes encoding developmental stage-specific leishmanolysin (GP63).利什曼原虫主要基因的靶向基因缺失,这些基因编码发育阶段特异性利什曼溶素(GP63)。
Mol Microbiol. 1998 Feb;27(3):519-30. doi: 10.1046/j.1365-2958.1998.00689.x.
5
Evaluation of DNA/DNA and prime-boost vaccination using LPG3 against Leishmania major infection in susceptible BALB/c mice and its antigenic properties in human leishmaniasis.评价 LPG3 对易感 BALB/c 小鼠感染利什曼原虫的 DNA/DNA 和初免-加强免疫接种及其在人类利什曼病中的抗原性。
Exp Parasitol. 2011 Mar;127(3):627-36. doi: 10.1016/j.exppara.2010.12.007. Epub 2010 Dec 25.
6
Disruption of the Putative Ribosome-Binding Motif of a Scaffold Protein Impairs Cytochrome Oxidase Subunit Expression in .支架蛋白的核糖体结合基序缺失会影响. 中的细胞色素氧化酶亚基的表达。
mSphere. 2019 Mar 6;4(2):e00644-18. doi: 10.1128/mSphere.00644-18.
7
Presentation of the Leishmania antigen LACK by infected macrophages is dependent upon the virulence of the phagocytosed parasites.受感染巨噬细胞对利什曼原虫抗原LACK的呈递取决于被吞噬寄生虫的毒力。
Eur J Immunol. 1999 Mar;29(3):762-73. doi: 10.1002/(SICI)1521-4141(199903)29:03<762::AID-IMMU762>3.0.CO;2-4.
8
T cells that react to the immunodominant Leishmania major LACK antigen prevent early dissemination of the parasite in susceptible BALB/c mice.对免疫显性利什曼原虫主要LACK抗原产生反应的T细胞可阻止寄生虫在易感的BALB/c小鼠体内早期扩散。
Infect Immun. 2001 Feb;69(2):1212-4. doi: 10.1128/IAI.69.2.1212-1214.2001.
9
Leishmania donovani p36(LACK) DNA vaccine is highly immunogenic but not protective against experimental visceral leishmaniasis.杜氏利什曼原虫p36(LACK)DNA疫苗具有高度免疫原性,但对实验性内脏利什曼病无保护作用。
Infect Immun. 2001 Aug;69(8):4719-25. doi: 10.1128/IAI.69.8.4719-4725.2001.
10
T-cell responses to immunodominant LACK antigen do not play a critical role in determining susceptibility of BALB/c mice to Leishmania mexicana.T细胞对免疫显性LACK抗原的反应在决定BALB/c小鼠对墨西哥利什曼原虫的易感性方面不发挥关键作用。
Infect Immun. 2001 Jan;69(1):617-21. doi: 10.1128/IAI.69.1.617-621.2001.

引用本文的文献

1
Recombinant Leishmania-activated C kinase as a novel antigenic candidate for immuno-diagnosis of visceral leishmaniasis occurring in India and Brazil.重组利什曼原虫激活的C激酶作为印度和巴西内脏利什曼病免疫诊断的新型抗原候选物。
Infect Dis Poverty. 2025 Jul 9;14(1):62. doi: 10.1186/s40249-025-01296-7.
2
A Proteogenomic Approach for the Identification of Virulence Factors in Leishmania Parasites.一种蛋白质基因组学方法用于鉴定利什曼原虫寄生虫中的毒力因子。
Methods Mol Biol. 2025;2859:279-296. doi: 10.1007/978-1-0716-4152-1_16.
3
Evaluation of a Novel Multi-Epitope Peptide Vaccine Candidate from LACK, LeIF, GP63, SMT Antigens of in BALB/c Mice.

本文引用的文献

1
Persistence without pathology in phosphoglycan-deficient Leishmania major.缺乏磷酸聚糖的硕大利什曼原虫无病理状态下的持续性
Science. 2003 Aug 29;301(5637):1241-3. doi: 10.1126/science.1087499.
2
The combination of DNA vectors expressing IL-12 + IL-18 elicits high protective immune response against cutaneous leishmaniasis after priming with DNA-p36/LACK and the cytokines, followed by a booster with a vaccinia virus recombinant expressing p36/LACK.在用DNA-p36/LACK和细胞因子进行初次免疫,随后用表达p36/LACK的重组痘苗病毒进行加强免疫后,表达IL-12 + IL-18的DNA载体组合引发了针对皮肤利什曼病的高度保护性免疫反应。
Microbes Infect. 2003 Feb;5(2):73-84. doi: 10.1016/s1286-4579(02)00077-1.
3
新型多表位肽疫苗候选物对 BALB/c 小鼠中 LACK、LeIF、GP63、SMT 抗原的评价。
Arch Razi Inst. 2022 Dec 31;77(6):2223-2233. doi: 10.22092/ARI.2022.358499.2238. eCollection 2022 Dec.
4
In silico designing of a novel polyvalent multi-subunit peptide vaccine leveraging cross-immunity against human visceral and cutaneous leishmaniasis: an immunoinformatics-based approach.基于免疫信息学的方法:利用针对人体内脏利什曼病和皮肤利什曼病的交叉免疫原性,设计新型多价多亚单位肽疫苗。
J Mol Model. 2023 Mar 16;29(4):99. doi: 10.1007/s00894-023-05503-w.
5
Leishmania tarentolae: a vaccine platform to target dendritic cells and a surrogate pathogen for next generation vaccine research in leishmaniases and viral infections.利什曼原虫:一种以树突状细胞为靶点的疫苗平台,也是针对利什曼病和病毒感染的下一代疫苗研究的替代病原体。
Parasit Vectors. 2023 Jan 26;16(1):35. doi: 10.1186/s13071-023-05651-1.
6
Identification of Epidemiology, Drug Resistance and Pathogenicity Biomarkers with Nanopore Sequencing.利用纳米孔测序技术鉴定流行病学、耐药性和致病性生物标志物
Microorganisms. 2022 Nov 14;10(11):2256. doi: 10.3390/microorganisms10112256.
7
Global distribution of treatment resistance gene markers for leishmaniasis.利什曼病治疗耐药基因标记物的全球分布。
J Clin Lab Anal. 2022 Aug;36(8):e24599. doi: 10.1002/jcla.24599. Epub 2022 Jul 9.
8
Proteomic Analysis of Membrane Components Reveals the Role of Activated Protein C Kinase in Host-Parasite Interaction.膜成分的蛋白质组学分析揭示了活化蛋白C激酶在宿主-寄生虫相互作用中的作用。
Pathogens. 2021 Sep 15;10(9):1194. doi: 10.3390/pathogens10091194.
9
Prediction of Key Proteins Via Topological Analysis of Protein-Protein Interaction Network.通过蛋白质-蛋白质相互作用网络的拓扑分析预测关键蛋白质
Galen Med J. 2018 Jun 12;7:e1129. doi: 10.22086/gmj.v0i0.1129. eCollection 2018.
10
Leishmaniasis.利什曼病
Indian J Crit Care Med. 2021 May;25(Suppl 2):S166-S170. doi: 10.5005/jp-journals-10071-23844.
The betagamma subunit of heterotrimeric G proteins interacts with RACK1 and two other WD repeat proteins.
异源三聚体G蛋白的βγ亚基与RACK1及另外两种WD重复蛋白相互作用。
J Biol Chem. 2002 Dec 20;277(51):49888-95. doi: 10.1074/jbc.M202755200. Epub 2002 Sep 30.
4
Rapid expansion and IL-4 expression by Leishmania-specific naive helper T cells in vivo.利什曼原虫特异性初始辅助性T细胞在体内的快速扩增及白细胞介素-4表达
Immunity. 2002 Aug;17(2):191-200. doi: 10.1016/s1074-7613(02)00363-1.
5
LACK-specific CD4(+) T cells that induce gamma interferon production in patients with localized cutaneous leishmaniasis during an early stage of infection.在局部皮肤利什曼病感染早期可诱导γ干扰素产生的LACK特异性CD4(+) T细胞。
Infect Immun. 2002 Jun;70(6):3122-9. doi: 10.1128/IAI.70.6.3122-3129.2002.
6
Impaired protein kinase C activation/translocation in Epstein-Barr virus-infected monocytes.爱泼斯坦-巴尔病毒感染的单核细胞中蛋白激酶C激活/易位受损。
J Biol Chem. 2002 Jul 5;277(27):24148-54. doi: 10.1074/jbc.M109036200. Epub 2002 Apr 23.
7
Targeted gene deletion in Leishmania major identifies leishmanolysin (GP63) as a virulence factor.利什曼原虫的靶向基因缺失鉴定出利什曼溶素(GP63)是一种毒力因子。
Mol Biochem Parasitol. 2002 Mar;120(1):33-40. doi: 10.1016/s0166-6851(01)00432-7.
8
Protective immune response against cutaneous leishmaniasis by prime/booster immunization regimens with vaccinia virus recombinants expressing Leishmania infantum p36/LACK and IL-12 in combination with purified p36.用表达婴儿利什曼原虫p36/LACK和IL-12的痘苗病毒重组体与纯化的p36联合进行初免/加强免疫方案对皮肤利什曼病的保护性免疫反应。
Microbes Infect. 2001 Jul;3(9):701-11. doi: 10.1016/s1286-4579(01)01426-5.
9
The interaction of Src and RACK1 is enhanced by activation of protein kinase C and tyrosine phosphorylation of RACK1.蛋白激酶C的激活以及RACK1的酪氨酸磷酸化增强了Src与RACK1之间的相互作用。
J Biol Chem. 2001 Jun 8;276(23):20346-56. doi: 10.1074/jbc.M101375200. Epub 2001 Mar 8.
10
Roles for beta II-protein kinase C and RACK1 in positive and negative signaling for superoxide anion generation in differentiated HL60 cells.βII-蛋白激酶C和RACK1在分化的HL60细胞中超氧阴离子生成的正向和负向信号传导中的作用。
J Biol Chem. 2001 Mar 23;276(12):8910-7. doi: 10.1074/jbc.M008326200. Epub 2000 Dec 18.